Quest Diagnostics (DGX) Deferred Taxes (2009 - 2026)

Quest Diagnostics has disclosed Deferred Taxes across 18 years of filings, most recently posting -$2.0 million for Q2 2026.

• In Q2 2026, Deferred Taxes fell 300.0% year-over-year to -$2.0 million; the TTM figure through Jun 2026 stood at $143.0 million (up 150.88% YoY), while the FY2025 annual figure was $105.0 million, up 707.69% from the prior year.
• Deferred Taxes came in at -$2.0 million for Q2 2026 at Quest Diagnostics, down from $48.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $110.0 million in Q3 2025 to a low of -$44.0 million in Q4 2022.
• Average Deferred Taxes over 5 years is $6.4 million, with a median of -$3.0 million recorded in 2023.
• Year-over-year, Deferred Taxes soared 3150.0% in 2022 and sank 350.0% in 2024.
• Over 5 years, Deferred Taxes stood at -$44.0 million in 2022, then jumped by 77.27% to -$10.0 million in 2023, then surged by 440.0% to $34.0 million in 2024, then sank by 138.24% to -$13.0 million in 2025, then jumped by 84.62% to -$2.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$2.0 million in Q2 2026, $48.0 million in Q1 2026, and -$13.0 million in Q4 2025.